Lipid-based drug delivery systems in the treatment of wet age-related macular degeneration

Research output: Contribution to journalReview ArticleResearchpeer-review

16 Citations (Scopus)


Recent advances in drug delivery technology have amplified potential opportunities to treat the debilitating diseases that affect the posterior segment of the eye in a less invasive and more efficient manner. Current methods for effective drug delivery to the back of the eye are hindered by many barriers and limitations. As a consequence, considerable efforts have been directed towards developing new materials to selectively deliver drug directly to the target site. This review focuses on lipid-based delivery systems which show promise in improving treatment for the most common disease of the posterior segment of the eye in the developed world, age-related macular degeneration, with an emphasis upon on-demand delivery systems as they have greater potential to overcome the current limitations.

Original languageEnglish
Pages (from-to)781-792
Number of pages12
JournalDrug Delivery and Translational Research
Issue number6
Publication statusPublished - 1 Dec 2016


  • Age-related macular degeneration
  • Intravitreal
  • Lipids
  • Liposomes
  • Stimuli responsive

Cite this